98 related articles for article (PubMed ID: 2199424)
1. Prophylactic use of mexiletine in the elderly with acute myocardial infarction.
Datta-Chaudhari ML; O'Brien TD
J Assoc Physicians India; 1990 Feb; 38(2):144-7. PubMed ID: 2199424
[TBL] [Abstract][Full Text] [Related]
2. International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT): II. Results from 24-hour electrocardiograms. IMPACT Research Group.
Eur Heart J; 1986 Sep; 7(9):749-59. PubMed ID: 3533546
[TBL] [Abstract][Full Text] [Related]
3. Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis.
Zarembski DG; Nolan PE; Slack MK; Caruso AC
Arch Intern Med; 1993 Dec; 153(23):2661-7. PubMed ID: 7504440
[TBL] [Abstract][Full Text] [Related]
4. Clinical antiarrhythmic efficacy of mexiletine: a review.
Kulbertus HE
Acta Cardiol Suppl; 1980; (25):111-20. PubMed ID: 6990663
[TBL] [Abstract][Full Text] [Related]
5. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group.
Eur Heart J; 1985 Mar; 6(3):199-226. PubMed ID: 2863148
[TBL] [Abstract][Full Text] [Related]
6. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
Capucci A; Di Pasquale G; Boriani G; Carini G; Balducelli M; Frabetti L; Carozzi A; Finzi A; Pinelli G; Magnani B
Int J Clin Pharmacol Res; 1991; 11(1):23-33. PubMed ID: 1714885
[TBL] [Abstract][Full Text] [Related]
7. A trial of prophylactic mexiletine in home coronary care.
Bell JA; Thomas JM; Isaacson JR; Snell NJ; Holt DW
Br Heart J; 1982 Sep; 48(3):285-90. PubMed ID: 7049204
[TBL] [Abstract][Full Text] [Related]
8. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.
Goldbourt U; Behar S; Reicher-Reiss H; Zion M; Mandelzweig L; Kaplinsky E
Arch Intern Med; 1993 Feb; 153(3):345-53. PubMed ID: 8285927
[TBL] [Abstract][Full Text] [Related]
9. [Mexiletine in patients with progressive infarction and reduced ventricular function: anti-arrhythmic efficacy and hemodynamic effects].
Zacà F; Ghinelli M; Bombardini T; De Collibus C; Zaccaria O; Steffanon L; Azzolini U; Valentini P; Puddu P
G Ital Cardiol; 1990 Jun; 20(6):569-75. PubMed ID: 2227228
[TBL] [Abstract][Full Text] [Related]
10. Oral captopril versus placebo among 14,962 patients with suspected acute myocardial infarction: a multicenter, randomized, double-blind, placebo controlled clinical trial. Chinese Cardiac Study (CCS-1) Collaborative Group.
Chin Med J (Engl); 1997 Nov; 110(11):834-8. PubMed ID: 9772413
[TBL] [Abstract][Full Text] [Related]
11. Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks.
Liu L;
Chin Med J (Engl); 2001 Feb; 114(2):115-8. PubMed ID: 11780187
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
13. Secondary prevention of myocardial infarction in the elderly.
Abrahamsen AM; Gundersen T; Rønnevik P
Curr Med Res Opin; 1982; 7(Suppl 1):68-78. PubMed ID: 7105797
[TBL] [Abstract][Full Text] [Related]
14. [Mexiletine therapy of ventricular extrasystoles in the acute phase of myocardial infarction].
Juillard A; Bouajina A; Barrillon A; Gay J; Gerbaux A
Ann Cardiol Angeiol (Paris); 1984; 33(2):117-20. PubMed ID: 6201121
[TBL] [Abstract][Full Text] [Related]
15. Effect of selenium supplementation after acute myocardial infarction.
Korpela H; Kumpulainen J; Jussila E; Kemilä S; Kääriäinen M; Kääriäinen T; Sotaniemi EA
Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):249-52. PubMed ID: 2685953
[TBL] [Abstract][Full Text] [Related]
16. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine].
Zehender M; Geibel A; Hust M; Hohnloser S; Meinertz T; Just H
Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118
[TBL] [Abstract][Full Text] [Related]
17. Effect of treatment with magnesium and potassium on mortality and reinfarction rate of patients with suspected acute myocardial infarction.
Singh RB; Singh NK; Niaz MA; Sharma JP
Int J Clin Pharmacol Ther; 1996 May; 34(5):219-25. PubMed ID: 8738859
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of mexiletine in chronic ventricular arrhythmias: a multicentre double-blind medium-term trial.
Poggesi L; Scarti L; Ieri A; Lanzetta T; Grazzini M; Del Bene P; Masini G; Del Citerna F; Carnovali M; Masotti G
Int J Clin Pharmacol Res; 1989; 9(4):269-75. PubMed ID: 2476406
[TBL] [Abstract][Full Text] [Related]
19. Does left ventricular function improve with L-carnitine after acute myocardial infarction?
Iyer R; Gupta A; Khan A; Hiremath S; Lokhandwala Y
J Postgrad Med; 1999; 45(2):38-41. PubMed ID: 10734331
[TBL] [Abstract][Full Text] [Related]
20. Mexiletine: long-term efficacy and hemodynamic actions in patients with ventricular arrhythmia.
Sami M; Lisbona R
Can J Cardiol; 1985; 1(4):251-8. PubMed ID: 2413974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
